3rd Aug 2011 07:00
Notice of Results
LONDON, UK, 3 August, 2011 - SkyePharma PLC (LSE: SKP) will announce its interim results for the six months ended 30 June 2011 on Thursday 18 August 2011. A recording of the event will be available on the Company's website at www.skyepharma.com.
For further information please contact:
SkyePharma PLC | |
Axel Müller, Chief Executive Officer | +44 207 881 0524 |
Peter Grant, Chief Financial Officer | |
Financial Dynamics | |
Jonathan Birt /Sue Quigley | +44 207 831 3113 |
About SkyePharma PLC
Using its proprietary drug delivery technologies, SkyePharma develops new formulations of known molecules to provide a clinical advantage and life-cycle extension. The Group has twelve approved products in the areas of oral, inhalation and topical delivery. The Group's products are marketed throughout the world by leading pharmaceutical companies. For more information, visit www.skyepharma.com.
Related Shares:
SKP.L